← TANDEM DIABETES CARE INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $84.2m | $107.6m | $183.9m | $362.3m | $498.8m | $702.8m | $801.2m | $747.7m | $940.2m | $1.0b | |
| Cost of Revenue | $60.7m | $63.5m | $94.0m | $168.1m | $238.3m | $326.6m | $388.2m | $380.0m | $450.6m | $468.7m | |
| Gross Profit | $23.6m | $44.1m | $89.8m | $194.2m | $260.5m | $376.2m | $413.0m | $367.7m | $489.6m | $546.0m | |
| Operating Expenses | $101.6m | $107.0m | $134.5m | $210.9m | $268.5m | $353.6m | $505.8m | $600.9m | $588.7m | $733.3m | |
| Operating Income (Loss) | ($78.1m) | ($62.9m) | ($44.6m) | ($16.7m) | ($8.0m) | $22.7m | ($92.8m) | ($233.2m) | ($99.1m) | ($187.3m) | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $300k | $300k | $300k | $300k | $1.2m | $2.2m | $2.0m | $1.9m | $1.9m | $2.5m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $83.5m | $73.0m | ($122.0m) | $24.9m | ($36.7m) | $15.2m | ($94.0m) | ($135.4m) | ($78.2m) | ($227.0m) | |
| Income (Loss) from Equity Method Investments | — | — | — | — | — | — | $0 | $0 | ($2.1m) | ($14.2m) | |
| Interest and Other Income | $296k | $239k | $1.5m | $3.3m | $1.6m | $674k | $6.1m | $22.9m | $18.0m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($83.5m) | ($73.0m) | ($122.6m) | ($24.6m) | ($36.3m) | $15.9m | ($92.9m) | ($220.3m) | ($91.9m) | ($200.3m) | |
| Net Income (Loss) Attributable to Parent | ($83.4m) | ($73.0m) | ($122.6m) | ($24.8m) | ($34.4m) | $15.6m | ($94.6m) | ($222.6m) | ($96.0m) | ($204.7m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | — | — | $15.6m | ($94.6m) | ($222.6m) | — | — | |
| Earnings Per Share, Basic | — | — | — | — | — | $0.25 | ($1.47) | ($3.43) | ($1.47) | ($3.04) | |
| Earnings Per Share, Diluted | — | — | — | — | — | $0.24 | ($1.47) | ($3.43) | ($1.47) | ($3.04) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 63.0m | 64.1m | 65.0m | 65.5m | 67.3m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 64.3m | 64.1m | 65.0m | 65.5m | 67.3m | |
| Research and Development Expense | $18.8m | $20.7m | $29.2m | $45.2m | $63.6m | $92.1m | — | — | — | — | |
| Selling, General and Administrative Expense | $82.8m | $86.4m | $105.2m | $165.7m | $204.9m | $261.5m | $335.7m | $352.5m | $389.8m | $445.0m | |
| Other Nonoperating Income (Expense) | ($5.4m) | ($10.1m) | ($77.9m) | ($7.9m) | ($28.3m) | ($6.8m) | ($4k) | $13.0m | $7.3m | ($13.0m) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $7.4m | $7.9m | |
| Current Income Tax Expense (Benefit) | $15k | $8k | $51k | $174k | $226k | $335k | $1.7m | $2.4m | $4.2m | $4.4m | |
| Income Tax Expense (Benefit) | ($15k) | $8k | $51k | $149k | ($1.9m) | $335k | $1.7m | $2.4m | $4.2m | $4.4m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.